Targets for active immunotherapy against pediatric solid tumors

被引:0
作者
J. F. M. Jacobs
P. G. Coulie
C. G. Figdor
G. J. Adema
I. J. M. de Vries
P. M. Hoogerbrugge
机构
[1] Radboud University Medical Centre Nijmegen,Department of Pediatric Hemato
[2] Université Catholique de Louvain,oncology
[3] Nijmegen Centre for Molecular Life Sciences/278 TIL,De Duve Institute
来源
Cancer Immunology, Immunotherapy | 2009年 / 58卷
关键词
Antigen; Cancer; Immunotherapy; Pediatrics;
D O I
暂无
中图分类号
学科分类号
摘要
The potential role of antibodies and T lymphocytes in the eradication of cancer has been demonstrated in numerous animal models and clinical trials. In the last decennia new strategies have been developed for the use of tumor-specific T cells and antibodies in cancer therapy. Effective anti-tumor immunotherapy requires the identification of suitable target antigens. The expression of tumor-specific antigens has been extensively studied for most types of adult tumors. Pediatric patients should be excellent candidates for immunotherapy since their immune system is more potent and flexible as compared to that of adults. So far, these patients do not benefit enough from the progresses in cancer immunotherapy, and one of the reasons is the paucity of tumor-specific antigens identified on pediatric tumors. In this review we discuss the current status of cancer immunotherapy in children, focusing on the identification of tumor-specific antigens on pediatric solid tumors.
引用
收藏
页码:831 / 841
页数:10
相关论文
共 50 条
[41]   Immunotherapy for solid tumors-a review for surgeons [J].
Saied, Abdul ;
Pillarisetty, Venu G. ;
Katz, Steven C. .
JOURNAL OF SURGICAL RESEARCH, 2014, 187 (02) :525-535
[42]   CYTOKINE COMBINATIONS IN IMMUNOTHERAPY FOR SOLID TUMORS - A REVIEW [J].
HEATON, KM ;
GRIMM, EA .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 37 (04) :213-219
[43]   Immunotherapy combinations for the treatment of patients with solid tumors [J].
Virginia Bluthgen, Maria ;
Bast, Neus ;
Recondo, Gonzalo .
FUTURE ONCOLOGY, 2020, 16 (23) :1715-1736
[44]   Challenges of evaluating immunotherapy efficacy in solid tumors [J].
Bai, Rilan ;
Li, Wenqian ;
Du, Nawen ;
Cui, Jiuwei .
CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (06) :853-861
[45]   LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target [J].
Lee, Su Jin ;
Byeon, Sun-Ju ;
Lee, Jeeyun ;
Park, Se Hoon ;
Park, Joon Oh ;
Park, Young Suk ;
Kang, Won Ki ;
Lim, Ho Yeong ;
Kim, Kyoung-Mee ;
Kim, Seung Tae .
JOURNAL OF IMMUNOTHERAPY, 2019, 42 (08) :279-283
[46]   Dynamic toxicity landscape of immunotherapy for solid tumors across treatment lines [J].
Liu, Lihui ;
Li, Sini ;
Wang, Guoqiang ;
Qu, Yan ;
Wang, Zhijie ;
Duan, Jianchun ;
Wang, Chao ;
Xue, Pei ;
Zhang, Xue ;
Ma, Zixiao ;
Bai, Hua ;
Wang, Jie .
JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (03) :186-196
[47]   Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review [J].
Indini, Alice ;
Rijavec, Erika ;
Ghidini, Michele ;
Tomasello, Gianluca ;
Cattaneo, Monica ;
Barbin, Francesca ;
Bareggi, Claudia ;
Galassi, Barbara ;
Gambini, Donatella ;
Grossi, Francesco .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) :1-18
[48]   Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12 [J].
Zaharoff, David A. ;
Hance, Kenneth W. ;
Rogers, Connie J. ;
Schlom, Jeffrey ;
Greiner, John W. .
JOURNAL OF IMMUNOTHERAPY, 2010, 33 (07) :697-705
[49]   Langerhans cells as targets for immunotherapy against skin cancer [J].
Stoitzner, Patrizia ;
Sparber, Florian ;
Tripp, Christoph H. .
IMMUNOLOGY AND CELL BIOLOGY, 2010, 88 (04) :431-437
[50]   Radiotherapeutical innovations in pediatric solid tumors [J].
Habrand, JL ;
Abdulkarim, B ;
Roberti, H .
PEDIATRIC BLOOD & CANCER, 2004, 43 (06) :622-628